Search details
1.
Correlation between E-cadherin/ß-catenin, Vimentin expression, clinicopathologic features and drug resistance prediction in naïve prostate cancer: A molecular and clinical study.
Genesis
; 62(1): e23543, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37649322
2.
Epithelial-mesenchymal transition dysregulation in prostate cancer: Insights from molecular unraveling and epidemiological analyses in Tunisia, North Africa.
Ann Hum Genet
; 2024 Apr 25.
Article
in English
| MEDLINE | ID: mdl-38661458
3.
Co-expression of Twist and Snai1: predictor of poor prognosis and biomarker of treatment resistance in untreated prostate cancer.
Mol Biol Rep
; 51(1): 226, 2024 Jan 28.
Article
in English
| MEDLINE | ID: mdl-38281235
4.
Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort.
Mol Biol Rep
; 49(2): 1233-1258, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34854013
5.
Association of a common genetic variant (insertion/deletion) in ACE gene with prostate cancer susceptibility in a Tunisian population.
J Clin Lab Anal
; 36(1): e24129, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34799866
6.
An insight into the diagnostic and prognostic value of HOX A13's expression in non-muscle invasive bladder cancer.
J Clin Lab Anal
; 36(9): e24606, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35853090
7.
The diagnostic applicability of A-type Lamin in non-muscle invasive bladder cancer.
Ann Diagn Pathol
; 54: 151808, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34438192
8.
Uncovering the expression patterns and the clinical significance of miR-182, miR-205, miR-27a and miR-369 in patients with urinary bladder cancer.
Mol Biol Rep
; 47(11): 8819-8830, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-33128684
9.
miR-143 expression profiles in urinary bladder cancer: correlation with clinical and epidemiological parameters.
Mol Biol Rep
; 47(2): 1283-1292, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31863330
10.
Polymorphisms in XPC gene and risk for prostate cancer.
Mol Biol Rep
; 46(1): 1117-1125, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30552616
11.
The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer.
Mol Biol Rep
; 46(5): 4743-4750, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31214962
12.
Expression patterns and bioinformatic analysis of miR-1260a and miR-1274a in Prostate Cancer Tunisian patients.
Mol Biol Rep
; 45(6): 2345-2358, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30250996
13.
Correction to: Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort.
Mol Biol Rep
; 49(2): 1259, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34977990
14.
Distribution of xenobiotic metabolising enzyme genotypes in different Tunisian populations.
Ann Hum Biol
; 44(4): 366-372, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-27978766
15.
Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.
Pediatr Hematol Oncol
; 33(3): 157-67, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-27184773
16.
An insight into the diagnostic, prognostic, and taxanes resistance of double zinc finger and homeodomain factor's expression in naïve prostate cancer.
3 Biotech
; 14(4): 106, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38476644
17.
Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population.
Mol Biol Rep
; 40(2): 1307-14, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23065291
18.
The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer.
Mol Biol Rep
; 40(6): 4109-14, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23640097
19.
[Does multiple myeloma response to induction therapy depend on plasma cell IL6 receptor gene expression?]. / L'expression de l'IL6-r par les plasmocytes influe-t-elle la réponse au traitement d'induction au cours du myélome multiple ?
Tunis Med
; 91(5): 337-41, 2013 May.
Article
in French
| MEDLINE | ID: mdl-23716328
20.
Next-generation sequencing of Tunisian Leigh syndrome patients reveals novel variations: impact for diagnosis and treatment.
Biosci Rep
; 42(9)2022 09 30.
Article
in English
| MEDLINE | ID: mdl-36093993